← All diseases

Kidney diseases

Gitelman syndrome

An inherited disease that disturbs the kidney's work of taking back salt. Potassium and magnesium in the blood are low. There may be muscle cramps, tiredness and a craving for salt.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

This page is translated from the Turkish original.

This disease is followed through the “Kidney diseases” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

The kidneys take salt from the urine back into the blood. In Gitelman syndrome this work cannot be done fully. Salt is lost in the urine. Along with it, the balance of potassium, magnesium and calcium is also disturbed. Symptoms usually begin in late childhood or the teenage years.

Which symptoms can occur?

Symptoms can differ greatly even within the same family. In most people the course is mild.

  • Painful muscle contractions, cramps and muscle weakness (common)
  • Dizziness and a craving for salt (common)
  • Tingling of the skin, most often on the face (common)
  • Extreme tiredness (in some people)
  • Low blood pressure (in some people)
  • Painful crystal deposits in a joint (in some people)
  • A risk of heart rhythm problems (in some people)

How is it diagnosed?

The doctor first rules out more common causes of low potassium. A blood test shows low potassium and magnesium. A urine test shows low calcium and high potassium. A genetic test confirms the diagnosis.

Treatment and care

The disease is lifelong. For now there is no definite cure, but care reduces the symptoms. The aim is to keep the salt balance in the blood. Most people take potassium and magnesium supplements every day. A diet high in salt and rich in potassium may be advised. A kidney specialist follows the person with regular blood tests. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

Gitelman syndrome is passed on through recessive inheritance. Two changed genes are needed to have the disease; one comes from the mother and one from the father. Carrier parents usually have no symptoms. For a carrier couple, the chance of an affected child in each pregnancy is 1 in 4. In marriages between relatives, the chance of two carriers coming together may be higher. Genetic counselling explains the risks to the family.

Source: MedlinePlus Genetics: Gitelman syndrome · NORD: Gitelman Syndrome · Orphanet: Gitelman syndrome (ORPHA:358)

Key facts

How is it inherited?
Autosomal recessive
When does it usually start?
Childhood
Gene(s) involved
SLC12A3, CLCNKB

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

We could not find a patient association specific to this disease.

For all rare diseases: Nadir Hastalıklar Federasyonu

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about Gitelman

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

ClinicalTrials.gov currently lists no active interventional studies for this disease. Last checked: October 7, 2026.

See all studies on ClinicalTrials.gov · Joining clinical trials

Kidney diseases: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:358

No separate ICD-11 code; WHO classifies this disease under: 5C64.41

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.